Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced gastric cancer (OGSG 0002).
Takiuchi H, Narahara H, Tsujinaka T, Gotoh M, Kawabe S, Katsu K, Iishi H, Tatsuta M, Fujitani K, Furukawa H, Taguchi T; Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG).
Takiuchi H, et al. Among authors: tatsuta m.
Jpn J Clin Oncol. 2005 Sep;35(9):520-5. doi: 10.1093/jjco/hyi148. Epub 2005 Sep 1.
Jpn J Clin Oncol. 2005.
PMID: 16141295
Clinical Trial.